Explore emerging IgA nephropathy therapies—complement and BAFF/APRIL inhibitors, targeted budesonide—and why long‑term safety data still lags. In this episode, Overcoming Access Barriers and Step-Edit ...
Quality of care (QoC) measures among patients with recurrent, papillary-only bacillus Calmette-Guérin (BCG)-experienced high-risk non-muscle invasive bladder cancer (HR-NMIBC). Real world outcomes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results